Abstract
A pollen sampling network was developed in the United States (US) to support an exploratory field study using a modified grass allergen subcutaneous immunotherapy (SCIT) product with MicroCrystalline Tyrosine (MCT) and Monophosphoryl Lipid A (MPL) as adjuvant system for allergic rhinoconjunctivitis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
